Using an algorithm to improve HIV care for health home members
Part of Immune system & allergy, Infections clinical trials.
This study tests a computer-based algorithm to help improve HIV care for people who are part of a special care management program called a Health Home. It aims to make sure you get the support and treatment you need.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be enrolled in one of the care management agencies that are part of the Community Care Management Partners (CCMP) Health Home.
- You must be living with HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a mobile health app or text-based tool can help young people with HIV stay on top of their treatment and medical appointments. The goal is to make it easier to manage HIV care using your phone.
This study looks at how to improve HIV care and viral suppression by making the clinic environment better for both patients and staff. It may help you stay in care and keep your viral load undetectable.
This study tests a program that offers HIV testing and connects people to prevention or care right in the Emergency Department. It aims to make it easier for anyone visiting the ER to get the HIV services they need.
This trial is looking at how to improve HIV care by using data and interviews to help clinics make better decisions. It doesn't require you to do anything different—your regular clinic data will be used to see how well appointments are kept.
This trial tests a new way to help primary care doctors offer routine HIV and hepatitis screening to their adult patients. It may make it easier to catch these infections early.
This study tests a program to help people living with HIV who have difficulty taking their medications consistently. The goal is to see if extra support can improve health outcomes.
Hear when a new HIV (Human Immunodeficiency Virus) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.